D. E. Shaw & Co., Inc. Moderna, Inc. Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 3,782,700 shares of MRNA stock, worth $104 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,782,700

Previous 5,636,151 32.89%

Holding current value

$104 Million

Previous $160 Million 34.68%

% of portfolio

0.08%

Previous 0.16%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$23.65 - $28.54 $43.2 Million - $52.2 Million	1,827,404 Added 32.42%	7,463,555 $206 Million
Q1 2025 May 15, 2025	BUY	$28.35 - $47.53 $110 Million - $184 Million	3,867,436 Added 218.66%	5,636,151 $160 Million
Q4 2024 Feb 14, 2025	BUY	$36.85 - $63.93 $55.6 Million - $96.5 Million	1,509,591 Added 582.57%	1,768,715 $73.5 Million
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $16.5 Million - $32.4 Million	259,124 New	259,124 $17.3 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $26.8 Million - $36.3 Million	-314,155 Reduced 86.74%	48,022 $5.12 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $21.1 Million - $31.7 Million	303,845 Added 520.89%	362,177 $36 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $1.95 Million - $2.55 Million	-20,175 Reduced 25.7%	58,332 $6.03 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $22.5 Million - $30.4 Million	-189,573 Reduced 70.72%	78,507 $9.54 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $40.6 Million - $58.9 Million	-298,928 Reduced 52.72%	268,080 $41.2 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $34.9 Million - $61.9 Million	294,842 Added 108.33%	567,008 $102 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $29 Million - $47.6 Million	245,352 Added 915.01%	272,166 $32.2 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $144 Million - $217 Million	-1,227,130 Reduced 97.86%	26,814 $3.83 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $30.5 Million - $56.6 Million	240,949 Added 23.79%	1,253,944 $216 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $58.5 Million - $95.5 Million	259,232 Added 34.39%	1,012,995 $257 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $204 Million - $446 Million	-920,545 Reduced 54.98%	753,763 $290 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $210 Million - $380 Million	1,616,152 Added 2778.99%	1,674,308 $393 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $333 Million - $568 Million	-3,051,745 Reduced 98.13%	58,156 $7.62 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $154 Million - $398 Million	2,343,772 Added 305.92%	3,109,901 $325 Million
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $24.8 Million - $43.2 Million	455,804 Added 146.88%	766,129 $54.2 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $7.79 Million - $21 Million	262,490 Added 548.74%	310,325 $19.9 Million
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $5.82 Million - $10.3 Million	-327,503 Reduced 87.26%	47,835 $1.43 Million
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $5.23 Million - $7.99 Million	375,338 New	375,338 $7.34 Million
Q3 2019 Nov 14, 2019	SELL	$12.26 - $18.07 $308,069 - $454,062	-25,128 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $344,253 - $712,127	25,128 New	25,128 $368,000

Others Institutions Holding MRNA

# of Institutions

862

Shares Held

266M

Call Options Held

28.5M

Put Options Held

34.9M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account